Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...
How are Americans feeling before Election Day?
Election season is in full swing, but as anyone can tell you, campaigns begin to enter their full speed much earlier in the ...
Nasdaq4d
Piper says Myriad appears to be trading down on GeneSight coverage change
Piper Sandler thinks Myriad Genetics (MYGN), which has seen its shares fall nearly 22% on Friday morning, is trading down on a coverage decision on GeneSight by UnitedHealth (UNH), which will take ...
EurekAlert!1y
The GeneSight Test (IMAGE)
With a simple cheek swab, the GeneSight test generates a report that gives healthcare providers insight into how a patient may metabolize or respond to certain psychiatric medications.
Kaleido Scope2y
Prescription for Precision: Using genetic information to guide drug therapy may revolutionize treatments
They are studying the impact of two different commercially available genetic tests: the GeneSight Psychotropic test and the GenoMind Genecept Assay. Each determines whether a patient has any known ...
Psychology Today2y
Blue Water Psychiatry
Your brain health is our business. We offer GeneSight® Psychotropic testing for those who may not be responding to multiple medication trials. We offer treatment for depression, anxiety ...